We’re proud of our scientists for the recent successful delivery of a client project. Metabolites of two drug substances were provided, using microbial biotransformation for one drug compound and late-stage chemical synthesis for the other. Here’s what our client had to say:
“The process of screening, scale-up and analysis of metabolites was truly seamless. We appreciated Hypha’s expertise and flexibility in providing us with different options to meet our needs. They are a valuable partner for tackling any metabolite isolation questions and a pleasure to work with.”
Director of DMPK, Biotech company, Montreal, Canada
Use of Hypha’s One-Stop Metabolite Shop screening approach enabled the most productive and cost-effective technique to be used for scaling up each metabolite, to enable successful delivery of a client project involving multiple drug compounds.
